Human study of iPS cells advances toward approval in Japan

A panel of Japan's Health Ministry has approved a clinical study involving induced pluripotent stem cells. The study is a type of pretrial clinical research that will focus on the use of iPS cells in treating eye disease. The decision could pave the way for final approval by the health minister.

View Full Article in:

Japan Times, The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY